Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Cineworld Falls On Warner Streaming Plans

Fri, 04th Dec 2020 10:33

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

BP, up 3.3%. The oil major was the best performing FTSE 100 stock after members of the OPEC+ cartel struck a deal to increase production over the coming months, but by less than anticipated in their previous accord.

----------

SSE, up 3.0%. The Perth, Scotland-based utility is selling a 10% stake in the UK Dogger Bank A and B project to Italian oil major Eni for GBP202.5 million. Eni will buy another 10% stake from Norway's Equinor to have 20% alongside SSE's 40% and Equinor's 40%.

----------

FTSE 100 - LOSERS

----------

Rolls-Royce, down 3.5%. The jet engine maker was the worst-performing blue chip stock, giving back some of this week's bumper gains. It had risen 16% on Thursday as positive vaccine developments boosted the prospects of global travel. The aerospace stock remains up 54% in the past month, though down 46% in the past year.

----------

FTSE 250 - WINNERS

----------

Micro Focus International, up 10%. The software firm was on Thursday touted by Amazon Web Services as one of the businesses that can help companies migrate data to the cloud. AWS noted Micro's deployment environment software which it provided to Kmart Australia.

----------

Premier Oil, up 6.7%. Like BP, the mid-cap oil company's shares rose following Thursday's OPEC+ meeting.

----------

FTSE 250 - LOSERS

----------

Cineworld Group, down 11%. AT&T subsidiary Warner Bros will release its entire 2021 slate of movies on HBO Max streaming and in theatres simultaneously, including "The Matrix 4" and Denis Villeneuve's "Dune" remake, the studio announced in a landmark response to the pandemic Thursday. The "hybrid model" will see films available on HBO Max streaming in the US for one month from the date of their theatrical release.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

N4 Pharma, up 52%. The Chellaston, England-based pharmaceutical company made further gains after it announced on Thursday that cancer drug Nuvec can be freeze dried and stored for 14 day without a significant drop in performance. N4 Pharma said Nuvec formulations which had been freeze dried and then stored for 14 days, either at room temperature or at four degrees celsius, showed no significant drop in in vitro transfection capability following its reconstitution.

----------

Hunters Property, up 44%. The Yorkshire-based estate agent confirmed it received a preliminary approach from Property Franchise Group over a potential takeover offer. Property Franchise shares were down 5.5%.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Petro Matad, down 8.7%. The oil firm said a meeting on the awarding of the Block XX exploitation licence in Mongolia has been postponed due to lockdown measures.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
18 Jun 2018 11:54

N4 Pharma Says Team Making Progress In Nuvec Manufacturing Process

LONDON (Alliance News) - Drug reformulator N4 Pharma PLC said Monday work to develop a manufacturing process for Nuvec has begun "well" with the team making progress.Nuvec is a to

Read more
9 May 2018 14:13

N4 Pharma Files Patent For Drug To Treat Premature Ejaculation

LONDON (Alliance News) - Pharmaceutical company N4 Pharma PLC announced on Wednesday it has filed a patent application for a treatment for premature ejaculation.N4 Pharm's drug is an of

Read more
25 Apr 2018 11:54

N4 Pharma Outlook Optimistic But Loss Widens After Reverse Takeover

LONDON (Alliance News) - N4 Pharma PLC on Wednesday said it remains optimistic for future as progresses its drug and vaccine development, but the company's loss widened in 2017 following its a

Read more
18 Apr 2018 12:15

N4 Pharma Starts Clinical Trial Of Reformulated Sildenafil

LONDON (Alliance News) - N4 Pharma PLC said Wednesday that it has commenced proof of concept clinical trial for erectile dysfunction treatment drug sildenafil, following the completion of the of a

Read more
9 Mar 2018 10:43

N4 Pharma Raises Nets GBP159,700 From Warrant Exercise (ALLISS)

LONDON (Alliance News) - N4 Pharma PLC said Friday it issued 1.9 million shares due to exercise of warrants, raising GBP159,700 for the pharmaceutical warrants

Read more
8 Mar 2018 13:34

N4 Pharma Unveils Two-Pronged Strategy For Nuvec Development

LONDON (Alliance News) - N4 Pharma PLC announced Thursday a two-fold development strategy for its Nuvec technology, as well as a new head of development for Nuvec.Nuvec

Read more
7 Mar 2018 12:41

N4 Pharma Raises Further GBP30,451 After Warrant Exercise (ALLISS)

LONDON (Alliance News) - N4 Pharma PLC said Wednesday it issued 358,245 shares due to exercise of warrants, raising GBP30,451 for the pharmaceutical warrants at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.